Mass Balance of the Indoleamine 2,3‐Dioxygenase Inhibitor Navoximod (GDC-0919) in Rats and Dogs: Unexpected Cyanide Release from Imidazo[5,1-<i>a</i>]isoindole and Species Differences in Glucuronidation-Reference-Cited by-同舟云学术

Mass Balance of the Indoleamine 2,3‐Dioxygenase Inhibitor Navoximod (GDC-0919) in Rats and Dogs: Unexpected Cyanide Release from Imidazo[5,1-a]isoindole and Species Differences in Glucuronidation

Published:2023-04-14 Issue:7 Volume:51 Page:862-872
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Wang Shuai^ORCID,Ma Shuguang,Chen Eugene,Wang Jing,Le Hoa,Hanlon Steven Paul,Binder Martin,Lee Wendy,Khojasteh S. Cyrus,Salphati Laurent

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference34 articles.

1. Mass Balance, Metabolite Profile, andIn Vitro-In VivoComparison of Clearance Pathways of Deleobuvir, a Hepatitis C Virus Polymerase Inhibitor

2. Enzymatic Detoxification of Cyanide: Clues from Pseudomonas aeruginosa Rhodanese

3. The role of drug metabolizing enzymes in clearance

4. Characterization of ornidazole metabolites in human bile after intravenous doses by ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry;Du;Acta Pharm Sin B,2012

5. Drug-Responsive and Tissue-Specific Alternative Expression of Multiple First Exons in Rat UDP-Glucuronosyltransferase Family 1 (UGT1) Gene Complex

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bioactivation and reactivity research advances – 2023 year in review;Drug Metabolism Reviews;2024-07-17

2. Biotransformation research advances – 2023 year in review;Drug Metabolism Reviews;2024-07-11

3. The Importance of Tracking “Missing” Metabolites: How and Why?;Journal of Medicinal Chemistry;2023-09-28